Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 11 of 11 entries
Sorted by: Best Match Show Resources per page
[Chronic inflammation from the viewpoint of the pathological anatomist].

Die Medizinische Welt

Lindner J.
PMID: 5780240
Med Welt. 1969 Feb 08;6:279-83.

No abstract available.

Cite
Lindner J. Die chronische Entzündung aus der Sicht des pathologischen Anatomen. [Chronic inflammation from the viewpoint of the pathological anatomist]. Med Welt. 1969;6:279-83
Lindner, J. (1969). Die chronische Entzündung aus der Sicht des pathologischen Anatomen. [Chronic inflammation from the viewpoint of the pathological anatomist]. Die Medizinische Welt, 6279-83.
Lindner, J. "Die chronische Entzündung aus der Sicht des pathologischen Anatomen." [Chronic inflammation from the viewpoint of the pathological anatomist]. Die Medizinische Welt vol. 6 (1969): 279-83.
Lindner J. Die chronische Entzündung aus der Sicht des pathologischen Anatomen. [Chronic inflammation from the viewpoint of the pathological anatomist]. Med Welt. 1969 Feb 08;6:279-83. German. PMID: 5780240.
Copy Download .nbib Format: NLM
Mechanistic simulations of inflammation: current state and future prospects.

Mathematical biosciences

Vodovotz Y, Constantine G, Rubin J, Csete M, Voit EO, An G.
PMID: 18835282
Math Biosci. 2009 Jan;217(1):1-10. doi: 10.1016/j.mbs.2008.07.013. Epub 2008 Aug 26.

Inflammation is a normal, robust physiological process. It can also be viewed as a complex system that senses and attempts to resolve homeostatic perturbations initiated from within the body (for example, in autoimmune disease) or from the outside (for...

Cite
Vodovotz Y, Constantine G, Rubin J, et al. Mechanistic simulations of inflammation: current state and future prospects. Math Biosci. 2008;217(1):1-10doi: 10.1016/j.mbs.2008.07.013.
Vodovotz, Y., Constantine, G., Rubin, J., Csete, M., Voit, E. O., & An, G. (2009). Mechanistic simulations of inflammation: current state and future prospects. Mathematical biosciences, 217(1), 1-10. https://doi.org/10.1016/j.mbs.2008.07.013
Vodovotz, Yoram, et al. "Mechanistic simulations of inflammation: current state and future prospects." Mathematical biosciences vol. 217,1 (2009): 1-10. doi: https://doi.org/10.1016/j.mbs.2008.07.013
Vodovotz Y, Constantine G, Rubin J, Csete M, Voit EO, An G. Mechanistic simulations of inflammation: current state and future prospects. Math Biosci. 2009 Jan;217(1):1-10. doi: 10.1016/j.mbs.2008.07.013. Epub 2008 Aug 26. PMID: 18835282; PMCID: PMC2667966.
Copy Download .nbib Format: NLM
A Talisman of Pathology.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Pederson T.
PMID: 26933093
FASEB J. 2016 Mar;30(3):1011. doi: 10.1096/fj.160301ufm.

No abstract available.

Cite
Pederson T. A Talisman of Pathology. FASEB J. 2016;30(3):1011doi: 10.1096/fj.160301ufm.
Pederson, T. (2016). A Talisman of Pathology. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 30(3), 1011. https://doi.org/10.1096/fj.160301ufm
Pederson, Thoru. "A Talisman of Pathology." FASEB journal : official publication of the Federation of American Societies for Experimental Biology vol. 30,3 (2016): 1011. doi: https://doi.org/10.1096/fj.160301ufm
Pederson T. A Talisman of Pathology. FASEB J. 2016 Mar;30(3):1011. doi: 10.1096/fj.160301ufm. PMID: 26933093.
Copy Download .nbib Format: NLM
Chemical factors and their role in inflammation.

Archives of pathology

MENKIN V.
PMID: 21028275
Arch Pathol (Chic). 1946 Apr;41:376-87.

No abstract available.

Cite
MENKIN V. Chemical factors and their role in inflammation. Arch Pathol (Chic). 1946;41:376-87
MENKIN, V. (1946). Chemical factors and their role in inflammation. Archives of pathology, 41376-87.
MENKIN, V. "Chemical factors and their role in inflammation." Archives of pathology vol. 41 (1946): 376-87.
MENKIN V. Chemical factors and their role in inflammation. Arch Pathol (Chic). 1946 Apr;41:376-87. PMID: 21028275.
Copy Download .nbib Format: NLM
Co-morbidities in people with COPD: a result of multiple diseases, or multiple manifestations of smoking and reactive inflammation?.

Primary care respiratory journal : journal of the General Practice Airways Group

Yawn BP, Kaplan A.
PMID: 18338090
Prim Care Respir J. 2008 Dec;17(4):199-205. doi: 10.3132/pcrj.2008.00021.

There has been increased awareness and recognition of COPD in both developed and developing nations. As people with COPD are identified and treated before they reach end-stage lung disease, the multiple morbidities associated with COPD have been recognised. These...

Cite
Yawn BP, Kaplan A. Co-morbidities in people with COPD: a result of multiple diseases, or multiple manifestations of smoking and reactive inflammation?. Prim Care Respir J. 2008;17(4):199-205doi: 10.3132/pcrj.2008.00021.
Yawn, B. P., & Kaplan, A. (2008). Co-morbidities in people with COPD: a result of multiple diseases, or multiple manifestations of smoking and reactive inflammation?. Primary care respiratory journal : journal of the General Practice Airways Group, 17(4), 199-205. https://doi.org/10.3132/pcrj.2008.00021
Yawn, Barbara P, and Kaplan, Alan. "Co-morbidities in people with COPD: a result of multiple diseases, or multiple manifestations of smoking and reactive inflammation?." Primary care respiratory journal : journal of the General Practice Airways Group vol. 17,4 (2008): 199-205. doi: https://doi.org/10.3132/pcrj.2008.00021
Yawn BP, Kaplan A. Co-morbidities in people with COPD: a result of multiple diseases, or multiple manifestations of smoking and reactive inflammation?. Prim Care Respir J. 2008 Dec;17(4):199-205. doi: 10.3132/pcrj.2008.00021. PMID: 18338090; PMCID: PMC6619900.
Copy Download .nbib Format: NLM
New Insights into the Complexity of Cancer and of Inflammatory Diseases.

Current medicinal chemistry

Biava PM, Nicolini A.
PMID: 31113340
Curr Med Chem. 2019;26(6):940. doi: 10.2174/092986732606190513093422.

No abstract available.

Cite
Biava PM, Nicolini A. New Insights into the Complexity of Cancer and of Inflammatory Diseases. Curr Med Chem. 2019;26(6):940doi: 10.2174/092986732606190513093422.
Biava, P. M., & Nicolini, A. (2019). New Insights into the Complexity of Cancer and of Inflammatory Diseases. Current medicinal chemistry, 26(6), 940. https://doi.org/10.2174/092986732606190513093422
Biava, Pier Mario, and Nicolini, Andrea. "New Insights into the Complexity of Cancer and of Inflammatory Diseases." Current medicinal chemistry vol. 26,6 (2019): 940. doi: https://doi.org/10.2174/092986732606190513093422
Biava PM, Nicolini A. New Insights into the Complexity of Cancer and of Inflammatory Diseases. Curr Med Chem. 2019;26(6):940. doi: 10.2174/092986732606190513093422. PMID: 31113340.
Copy Download .nbib Format: NLM
[General pathology of inflammation].

Polski tygodnik lekarski

KRUS S.
PMID: 13236610
Pol Tyg Lek (Wars). 1954 Aug 09;9(32):1017-9; contd.

No abstract available.

Cite
KRUS S. Patologia ogólna zapalenia. [General pathology of inflammation]. Pol Tyg Lek (Wars). 1954;9(32):1017-9; contd
KRUS, S. (1954). Patologia ogólna zapalenia. [General pathology of inflammation]. Polski tygodnik lekarski, 9(32), 1017-9; contd.
KRUS, S. "Patologia ogólna zapalenia." [General pathology of inflammation]. Polski tygodnik lekarski vol. 9,32 (1954): 1017-9; contd.
KRUS S. Patologia ogólna zapalenia. [General pathology of inflammation]. Pol Tyg Lek (Wars). 1954 Aug 09;9(32):1017-9; contd. Polish. PMID: 13236610.
Copy Download .nbib Format: NLM
[On the origin of inflammation cells].

Medizinische Klinik

FASSKE E.
PMID: 13698317
Med Klin. 1961 Aug 04;56:1313-6.

No abstract available.

Cite
FASSKE E. [On the origin of inflammation cells]. Med Klin. 1961;56:1313-6
FASSKE, E. (1961). [On the origin of inflammation cells]. Medizinische Klinik, 561313-6.
FASSKE, E. "[On the origin of inflammation cells]." Medizinische Klinik vol. 56 (1961): 1313-6.
FASSKE E. [On the origin of inflammation cells]. Med Klin. 1961 Aug 04;56:1313-6. German. PMID: 13698317.
Copy Download .nbib Format: NLM
Tissue inflammatory cytology in clinical states.

American journal of clinical pathology

TORRE CM, LEIKIN SL.
PMID: 13838930
Am J Clin Pathol. 1959 Oct;32:335-45. doi: 10.1093/ajcp/32.4.335.

No abstract available.

Cite
TORRE CM, LEIKIN SL. Tissue inflammatory cytology in clinical states. Am J Clin Pathol. 1959;32:335-45doi: 10.1093/ajcp/32.4.335.
TORRE, C. M., & LEIKIN, S. L. (1959). Tissue inflammatory cytology in clinical states. American journal of clinical pathology, 32335-45. https://doi.org/10.1093/ajcp/32.4.335
TORRE, C M, and LEIKIN, S L. "Tissue inflammatory cytology in clinical states." American journal of clinical pathology vol. 32 (1959): 335-45. doi: https://doi.org/10.1093/ajcp/32.4.335
TORRE CM, LEIKIN SL. Tissue inflammatory cytology in clinical states. Am J Clin Pathol. 1959 Oct;32:335-45. doi: 10.1093/ajcp/32.4.335. PMID: 13838930.
Copy Download .nbib Format: NLM
Are mesenchymal stem cells and derived extracellular vesicles valuable to halt the COVID-19 inflammatory cascade? Current evidence and future perspectives.

Thorax

Monguió-Tortajada M, Bayes-Genis A, Rosell A, Roura S.
PMID: 33323479
Thorax. 2021 Feb;76(2):196-200. doi: 10.1136/thoraxjnl-2020-215717. Epub 2020 Dec 15.

No abstract available.

Cite
Monguió-Tortajada M, Bayes-Genis A, Rosell A, et al. Are mesenchymal stem cells and derived extracellular vesicles valuable to halt the COVID-19 inflammatory cascade? Current evidence and future perspectives. Thorax. 2020;76(2):196-200doi: 10.1136/thoraxjnl-2020-215717.
Monguió-Tortajada, M., Bayes-Genis, A., Rosell, A., & Roura, S. (2021). Are mesenchymal stem cells and derived extracellular vesicles valuable to halt the COVID-19 inflammatory cascade? Current evidence and future perspectives. Thorax, 76(2), 196-200. https://doi.org/10.1136/thoraxjnl-2020-215717
Monguió-Tortajada, Marta, et al. "Are mesenchymal stem cells and derived extracellular vesicles valuable to halt the COVID-19 inflammatory cascade? Current evidence and future perspectives." Thorax vol. 76,2 (2021): 196-200. doi: https://doi.org/10.1136/thoraxjnl-2020-215717
Monguió-Tortajada M, Bayes-Genis A, Rosell A, Roura S. Are mesenchymal stem cells and derived extracellular vesicles valuable to halt the COVID-19 inflammatory cascade? Current evidence and future perspectives. Thorax. 2021 Feb;76(2):196-200. doi: 10.1136/thoraxjnl-2020-215717. Epub 2020 Dec 15. PMID: 33323479; PMCID: PMC7815888.
Copy Download .nbib Format: NLM
Obesity, a major risk factor for immunity and severe outcomes of COVID-19.

Bioscience reports

Amin MT, Fatema K, Arefin S, Hussain F, Bhowmik DR, Hossain MS.
PMID: 34350941
Biosci Rep. 2021 Aug 27;41(8). doi: 10.1042/BSR20210979.

An influenza-like virus named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for COVID-19 disease and spread worldwide within a short time. COVID-19 has now become a significant concern for public health. Obesity is highly prevalent worldwide and is...

Cite
Amin MT, Fatema K, Arefin S, et al. Obesity, a major risk factor for immunity and severe outcomes of COVID-19. Biosci Rep. 2021;41(8)doi: 10.1042/BSR20210979.
Amin, M. T., Fatema, K., Arefin, S., Hussain, F., Bhowmik, D. R., & Hossain, M. S. (2021). Obesity, a major risk factor for immunity and severe outcomes of COVID-19. Bioscience reports, 41(8), . https://doi.org/10.1042/BSR20210979
Amin, Mohammad Tohidul, et al. "Obesity, a major risk factor for immunity and severe outcomes of COVID-19." Bioscience reports vol. 41,8 (2021). doi: https://doi.org/10.1042/BSR20210979
Amin MT, Fatema K, Arefin S, Hussain F, Bhowmik DR, Hossain MS. Obesity, a major risk factor for immunity and severe outcomes of COVID-19. Biosci Rep. 2021 Aug 27;41(8). doi: 10.1042/BSR20210979. PMID: 34350941; PMCID: PMC8380923.
Copy Download .nbib Format: NLM
Showing 1 to 11 of 11 entries